Evidence map›Paper›PMID 31658725›Full record

Trial reportNutrients2019

The Effectiveness of Different Doses of Iron Supplementation and the Prenatal Determinants of Maternal Iron Status in Pregnant Spanish Women: ECLIPSES Study.

Lucía Iglesias Vázquez, Victoria Arija, Núria Aranda, Estefanía Aparicio, Núria Serrat, Francesc Fargas, Francisca Ruiz, Meritxell Pallejà, Pilar Coronel, Mercedes Gimeno and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Daily oral iron supplementation during pregnancy.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Lucía Iglesias VázquezDepartment of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, 43201 Reus, Spain. lucia.iglesias@urv.cat.ORCID 0000-0001-7131-4144
Victoria ArijaDepartment of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, 43201 Reus, Spain. victoria.arija@urv.cat.
Núria ArandaDepartment of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, 43201 Reus, Spain. nuria.aranda@urv.cat.
Estefanía AparicioDepartment of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, 43201 Reus, Spain. estefania.aparicio@urv.cat.
Núria SerratClinical Laboratory, University Hospital Joan XXIII, Institut Català de la Salut, Generalitat de Catalunya, 43005 Tarragona, Spain. nserrat.tarte.ics@gencat.cat.ORCID 0000-0002-0064-2017
Francesc FargasSexual and Reproductive Health Service of Reus-Tarragona, Institut Català de la Salut, Generalitat de Catalunya, 43202 Tarragona, Spain. ffargas.tarte.ics@gencat.cat.
Francisca RuizSexual and Reproductive Health Service of Reus-Tarragona, Institut Català de la Salut, Generalitat de Catalunya, 43202 Tarragona, Spain. paqui.r.d@hotmail.com.
Meritxell PallejàTarragona-Reus Research Support Unit, Jordi Gol University Institute for Primary Care Research, 43202 Tarragona, Spain. meritxell.palleja@urv.cat.
Pilar CoronelMeiji Pharma Spain S.A. (formerly Tedec-Meiji Farma S.A.) Alcalá de Henares, 28802 Madrid, Spain. p.coronel@tedecmeiji.com.
Mercedes GimenoMeiji Pharma Spain S.A. (formerly Tedec-Meiji Farma S.A.) Alcalá de Henares, 28802 Madrid, Spain. m.gimeno@tedecmeiji.com.
Josep BasoraTarragona-Reus Research Support Unit, Jordi Gol University Institute for Primary Care Research, 43202 Tarragona, Spain. josep.basora@urv.cat.
Generalitat de Catalunya · ESUniversitat Rovira i Virgili · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESMeiji Pharma Spain · ESInstituto de Salud Carlos III · ES

Funding

Instituto de Salud Carlos III PI12/02777
6 · The paper itself

Abstract

Iron deficiency (ID), anemia, iron deficiency anemia (IDA) and excess iron (hemoconcentration) harm maternal-fetal health. We evaluated the effectiveness of different doses of iron supplementation adjusted for the initial levels of hemoglobin (Hb) on maternal iron status and described some associated prenatal determinants. The ECLIPSES study included 791 women, randomized into two groups: Stratum 1 (Hb = 110-130g/L, received 40 or 80mg iron daily) and Stratum 2 (Hb > 130g/L, received 20 or 40mg iron daily). Clinical, biochemical, and genetic information was collected during pregnancy, as were lifestyle and sociodemographic characteristics. In Stratum 1, using 80 mg/d instead of 40 mg/d protected against ID on week 36. Only women with ID on week 12 benefited from the protection against anemia and IDA by increasing Hb levels. In Stratum 2, using 20 mg/d instead of 40 mg/d reduced the risk of hemoconcentration in women with initial serum ferritin (SF) ≥ 15 μg/L, while 40 mg/d improved SF levels on week 36 in women with ID in early pregnancy. Mutations in the

Indexed as

Anemia, Iron-DeficiencyPregnancy Complications, HematologicAdultDietary SupplementsFemaleFerritinsHemochromatosis ProteinHemoglobinsHumansIronPregnancyPrenatal CareSpainTreatment OutcomeYoung AdultFerritinsHemochromatosis ProteinHemoglobinsHFE protein, humanIronhemoglobinHFE geneiron statusiron storesiron supplementationpregnancyrandomized controlled trialserum ferritin

Identifiers

PMID31658725
PMCPMC6835785
OpenAlexW2979882759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.